Research Article

Development of Zero-Order Sustained-Release Capsules Containing Hot Melt Extruded Flurbiprofen-Loaded Pellets

Volume: 56 Number: 1 May 21, 2026

Development of Zero-Order Sustained-Release Capsules Containing Hot Melt Extruded Flurbiprofen-Loaded Pellets

Abstract

Background and Aims: The aim of this study was to develop flurbiprofen-loaded pharmaceutical filaments using the HME technique, transform the filaments into pellets of appropriate size for capsule filling, and compare the drug release profile of the capsules with commercially available extended-release flurbiprofen capsules in the Turkish market. This study offers significant potential for industrial applicability and scalability by using the HME technique as an innovative production method and improving the solubility and release profile of flurbiprofen.

Methods: Flurbiprofen-loaded filaments were fabricated using the HME technique at 110°C. Filaments were characterised through thermal, molecular, and crystallinity analyses. Drug release studies were systematically conducted in comparison with commercially available flurbiprofen preparations.

Results: Filaments were successfully obtained using the HME technique. The excipients incorporated into the formulations were confirmed to be compatible with flurbiprofen. DSC and XRD analyses showed the transformation of flurbiprofen into an amorphous form. The F2 formulation demonstrated compliance with zero-order release kinetics and exhibited a dissolution profile comparable to that of commercial preparations.

Conclusion: In this study, flurbiprofen-loaded filaments were produced via the HME technique, filled into capsules, and compared with four commercial flurbiprofen capsules. The F2 formulation exhibited a release profile similar to commercial products, following zero-order kinetics. The findings revealed the feasibility of the HME technique for developing capsule dosage forms through filament production, while indicating that the F2 formulation could be considered an alternative to commercial preparations.

Keywords

References

  1. Alshahrani, S. M., Lu, W., Park, J.-B., Morott, J. T., Alsulays, B. B., Majumdar, S., Langley, N., Kolter, K., Gryczke, A., & Repka, M. A. (2015). Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF. AAPS PharmSciTech, 16, 824-834. https://doi.org/10.1208/s12249-014-0269-6 google scholar
  2. Aminu, N., Chan, S.-Y., Mumuni, M. A., Umar, N. M., Tanko, N., Zauro, S. A., Aminu, A., & Toh, S.-M. (2021). Physicochemical compatibility studies of triclosan and flurbiprofen with excipients of pharmaceutical formulation using binary, ternary, and multi-combination approach. Future Journal of Pharmaceutical Sciences, 7, 1-16. https://doi.org/10.1186/s43094-021-00302-7 google scholar
  3. Bagde, A., Kouagou, E., & Singh, M. (2022). Formulation of topical flurbiprofen solid lipid nanoparticle gel formulation using hot melt extrusion technique. AAPS PharmSciTech, 23(7), 257. https://doi.org/10.1208/s12249-022-02410-w google scholar
  4. Butreddy, A., Bandari, S., & Repka, M. A. (2021). Quality-by-design in hot melt extrusion based amorphous solid dispersions: An industrial perspective on product development. European Journal of Pharmaceutical Sciences, 158, 105655. https:// doi.org/10.1016/j.ejps.2020.105655 google scholar
  5. Chen, Y.-C., Moseson, D. E., Richard, C. A., Swinney, M. R., Horava, S. D., Oucherif, K. A., Cox, A. L., Hawkins, E. D., Li, Y., & DeNeve, D. F. (2022). Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam. Journal of Controlled Release, 342, 189-200. https://doi.org/10.1016/j.jconrel.2021.12.038 google scholar
  6. Daravath, B., Naveen, C., Vemula, S. K., & Tadikonda, R. R. (2018). Solubility and dissolution enhancement of flurbiprofen by solid dispersion using hydrophilic carriers. Brazilian Journal of Pharmaceutical Sciences, 53. https://doi.org/10. 1590/s2175-97902017000400010 google scholar
  7. Daravath, B., Tadikonda, R. R., & Vemula, S. K. (2015). Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen. Drug Development and Industrial Pharmacy, 41(8), 1254-1262. https://doi.org/10.3109/03639045.2014. 940963 google scholar
  8. Darwich, M., Mohylyuk, V., Kolter, K., Bodmeier, R., & Dashevskiy, A. (2023). Enhancement of itraconazole solubility and release by hot-melt extrusion with Solu-plus®. Journal of Drug Delivery Science and Technology, 81, 104280. https:// doi.org/10.1016/j.jddst.2023.104280 google scholar

Details

Primary Language

English

Subjects

Pharmaceutical Sciences, Pharmaceutical Delivery Technologies, Pharmacology and Pharmaceutical Sciences (Other)

Journal Section

Research Article

Publication Date

May 21, 2026

Submission Date

September 23, 2025

Acceptance Date

January 21, 2026

Published in Issue

Year 2026 Volume: 56 Number: 1

APA
Cebecioğlu, Ş., Yılmaz, A., Pınarbaslı, O., & Takka, S. (2026). Development of Zero-Order Sustained-Release Capsules Containing Hot Melt Extruded Flurbiprofen-Loaded Pellets. İstanbul Journal of Pharmacy, 56(1), 8-16. https://doi.org/10.26650/IstanbulJPharm.2026.1789592
AMA
1.Cebecioğlu Ş, Yılmaz A, Pınarbaslı O, Takka S. Development of Zero-Order Sustained-Release Capsules Containing Hot Melt Extruded Flurbiprofen-Loaded Pellets. iujp. 2026;56(1):8-16. doi:10.26650/IstanbulJPharm.2026.1789592
Chicago
Cebecioğlu, Şule, Aysel Yılmaz, Onur Pınarbaslı, and Sevgi Takka. 2026. “Development of Zero-Order Sustained-Release Capsules Containing Hot Melt Extruded Flurbiprofen-Loaded Pellets”. İstanbul Journal of Pharmacy 56 (1): 8-16. https://doi.org/10.26650/IstanbulJPharm.2026.1789592.
EndNote
Cebecioğlu Ş, Yılmaz A, Pınarbaslı O, Takka S (May 1, 2026) Development of Zero-Order Sustained-Release Capsules Containing Hot Melt Extruded Flurbiprofen-Loaded Pellets. İstanbul Journal of Pharmacy 56 1 8–16.
IEEE
[1]Ş. Cebecioğlu, A. Yılmaz, O. Pınarbaslı, and S. Takka, “Development of Zero-Order Sustained-Release Capsules Containing Hot Melt Extruded Flurbiprofen-Loaded Pellets”, iujp, vol. 56, no. 1, pp. 8–16, May 2026, doi: 10.26650/IstanbulJPharm.2026.1789592.
ISNAD
Cebecioğlu, Şule - Yılmaz, Aysel - Pınarbaslı, Onur - Takka, Sevgi. “Development of Zero-Order Sustained-Release Capsules Containing Hot Melt Extruded Flurbiprofen-Loaded Pellets”. İstanbul Journal of Pharmacy 56/1 (May 1, 2026): 8-16. https://doi.org/10.26650/IstanbulJPharm.2026.1789592.
JAMA
1.Cebecioğlu Ş, Yılmaz A, Pınarbaslı O, Takka S. Development of Zero-Order Sustained-Release Capsules Containing Hot Melt Extruded Flurbiprofen-Loaded Pellets. iujp. 2026;56:8–16.
MLA
Cebecioğlu, Şule, et al. “Development of Zero-Order Sustained-Release Capsules Containing Hot Melt Extruded Flurbiprofen-Loaded Pellets”. İstanbul Journal of Pharmacy, vol. 56, no. 1, May 2026, pp. 8-16, doi:10.26650/IstanbulJPharm.2026.1789592.
Vancouver
1.Şule Cebecioğlu, Aysel Yılmaz, Onur Pınarbaslı, Sevgi Takka. Development of Zero-Order Sustained-Release Capsules Containing Hot Melt Extruded Flurbiprofen-Loaded Pellets. iujp. 2026 May 1;56(1):8-16. doi:10.26650/IstanbulJPharm.2026.1789592